open access

Ahead of Print
Research paper
Published online: 2023-12-06
Get Citation

Self-reported participation in cervical cancer screening among Polish women in 2004–2019

Irmina M. Michalek1, Marta Manczuk1, Florentino Luciano Caetano dos Santos2, Anna Macios3, Joanna Didkowska1, Andrzej Nowakowski34
·
Pubmed: 38099666
Affiliations
  1. Department of Cancer Epidemiology and Primary Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  2. Harvard Business School, Harvard University, Boston, MA, United States
  3. Department of Cancer Prevention, Cervical Cancer Prevention Clinic and Central Coordination Center for Cervical Cancer Screening Program, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  4. Division of Surgical Robotics, Voivodship Specialist Hospital, Lublin, Poland

open access

Ahead of Print
ORIGINAL PAPERS Gynecology
Published online: 2023-12-06

Abstract

Objectives: We aimed to assess self-reported participation in cervical cancer screening among Polish women between 2004 and 2019 and to identify the groups with the lowest participation rate.

Material and methods: Data on declared participation in cervical cancer screening were obtained from the European Health Interview Survey from 2004 to 2019.

Results: In 2019, 86.7% of Polish women aged ≥ 15 years declared that they had ever undergone a Pap test. Compared to 2004, the coverage of ever-screened women improved by 16.6 percentage points. The proxy population coverage was 72.9%. The highest proportion of women who underwent a Pap smear in the last three years was observed among those aged 35–44 years and 25–34 years (84.0% and 83.2%, respectively), and the lowest among women aged ≥ 75 years (20.5%). The proportion screened within the last three years also varied by education (up to lower secondary education 26.4%, up to post-secondary non-tertiary education 62.8%, and the highest level of education 83.7%), urbanization (large cities 66.7%, suburbs, and smaller cities 62.8%, and rural areas 59.0%), income (poorest households 42.5%, wealthiest households 70.6%), and declared health status (best 68.9%, worst 41.4%). The lowest participation in screening was observed in the southeastern regions and the highest in the northwestern regions of Poland.

Conclusions: In Poland, in 2019, the approximate coverage of cervical cancer screening was high compared to other European countries and has improved over the last 15 years. A complete screening registry is required to confirm questionnaire-based self-reported data. Targeted interventions should be implemented to address low participation in the identified regions and socioeconomic groups.

Abstract

Objectives: We aimed to assess self-reported participation in cervical cancer screening among Polish women between 2004 and 2019 and to identify the groups with the lowest participation rate.

Material and methods: Data on declared participation in cervical cancer screening were obtained from the European Health Interview Survey from 2004 to 2019.

Results: In 2019, 86.7% of Polish women aged ≥ 15 years declared that they had ever undergone a Pap test. Compared to 2004, the coverage of ever-screened women improved by 16.6 percentage points. The proxy population coverage was 72.9%. The highest proportion of women who underwent a Pap smear in the last three years was observed among those aged 35–44 years and 25–34 years (84.0% and 83.2%, respectively), and the lowest among women aged ≥ 75 years (20.5%). The proportion screened within the last three years also varied by education (up to lower secondary education 26.4%, up to post-secondary non-tertiary education 62.8%, and the highest level of education 83.7%), urbanization (large cities 66.7%, suburbs, and smaller cities 62.8%, and rural areas 59.0%), income (poorest households 42.5%, wealthiest households 70.6%), and declared health status (best 68.9%, worst 41.4%). The lowest participation in screening was observed in the southeastern regions and the highest in the northwestern regions of Poland.

Conclusions: In Poland, in 2019, the approximate coverage of cervical cancer screening was high compared to other European countries and has improved over the last 15 years. A complete screening registry is required to confirm questionnaire-based self-reported data. Targeted interventions should be implemented to address low participation in the identified regions and socioeconomic groups.

Get Citation

Keywords

early detection of cancer; cervical cancer; papanicolaou test; cytology

Supp./Additional Files (1)
Supplementary material
Download
67KB
About this article
Title

Self-reported participation in cervical cancer screening among Polish women in 2004–2019

Journal

Ginekologia Polska

Issue

Ahead of Print

Article type

Research paper

Published online

2023-12-06

Page views

202

Article views/downloads

134

DOI

10.5603/gpl.96634

Pubmed

38099666

Keywords

early detection of cancer
cervical cancer
papanicolaou test
cytology

Authors

Irmina M. Michalek
Marta Manczuk
Florentino Luciano Caetano dos Santos
Anna Macios
Joanna Didkowska
Andrzej Nowakowski

References (22)
  1. International Agency for Research on Cancer. GLOBOCAN 2020. https://gco.iarc.fr/today/home (accessed on 24-07-2023).
  2. Polish National Cancer Registry. Reports 2023. https://onkologia.org.pl/pl/raporty (accessed on 24-07-2023).
  3. Markowitz L, Dunne E, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(Rr-2): 1–24.
  4. European Centre for Disease Prevention and Control. Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction 2020. https://www.ecdc.europa.eu/en/publications-data/guidance-hpv-vaccination-eu-focus-boys-people-living-hiv-9vHPV-vaccine (accessed on 24-07-2023).
  5. https://dziennikmz.mz.gov.pl/legalact/2023/16/ (accessed on 24-07-2023).
  6. Bruni L, Serrano B, Roura E, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022; 10(8): e1115–e1127.
  7. Polish Ministry of Health. Profilaktyka raka szyjki macicy. 2023. https://pacjent.gov.pl/program-profilaktyczny/profilaktyka-raka-szyjki-macicy (accessed on 24-07-2023).
  8. Health status of population in Poland in 2019. Statistics Poland, Warsaw 2021.
  9. United Nations Educational, Scientific, and Cultural Organization. International Standard Classification of Education (ISCED) 2011. http://uis.unesco.org/en/topic/international-standard-classification-education-isced (accessed on 24-07-2023).
  10. Eurostat. The degree of urbanisation (DEGURBA). https://ec.europa.eu/eurostat/web/degree-of-urbanisation/background (accessed on 24-07-2023).
  11. Statistics Poland. Degree of urbanisation (DEGURBA). https://stat.gov.pl/en/regional-statistics/classification-of-territorial-units/union-territorial-typologies-tercet/degree-of-urbanisation-degurba/ (accessed on 24-07-2023).
  12. Eurostat. Statistics explained. Equivalised income. 2021. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Glossary:Equivalised_income#:~:text=Equivalised%20income%20is%20a%20measure,poverty%20and%20social%20exclusion%20indicator (accessed on 24-07-2023).
  13. Eurostat. European health interview survey. 2019. https://ec.europa.eu/eurostat/web/microdata/european-health-interview-survey (accessed on 24-07-2023).
  14. Didkowska J, Wojciechowska U, Michalek IM, et al. Cancer incidence and mortality in Poland in 2019. Sci Rep. 2022; 12(1): 10875.
  15. Segi M. Cancer mortality for selected sites in 24 countries (1950–57). Department of Public Health. Tohoku University of Medicine, Sendai, Japan 1960.
  16. Eurostat. Eurostat – Health care activities, screening definitions 2021. https://ec.europa.eu/eurostat/cache/metadata/Annexes/hlth_ps_scre_esms_an1.pdf (accessed on 24-07-2023).
  17. Staley H, Shiraz A, Shreeve N, et al. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev. 2021; 9(9): CD002834.
  18. Rees I, Jones D, Chen H, et al. Interventions to improve the uptake of cervical cancer screening among lower socioeconomic groups: A systematic review. Prev Med. 2018; 111: 323–335.
  19. Nessler K, Ball F, Chan SK, et al. Barriers and attitudes towards cervical cancer screening in primary healthcare in Poland - doctors' perspective. BMC Fam Pract. 2021; 22(1): 260.
  20. Nessler K, Chan SK, Ball F, et al. Impact of family physicians on cervical cancer screening: cross-sectional questionnaire-based survey in a region of southern Poland. BMJ Open. 2019; 9(8): e031317.
  21. Polish Ministry of Health. Jakie są kompetencje położnej POZ?. 2022. https://pacjent.gov.pl/system-opieki-zdrowotnej/jakie-sa-kompetencje-poloznej-poz (accessed on 24-07-2023).
  22. Williams J, Rakovac I, Victoria J, et al. Cervical cancer testing among women aged 30-49 years in the WHO European Region. Eur J Public Health. 2021; 31(4): 884–889.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl